ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Radiopharmaceutical Production Operator II at Telix Pharmaceuticals - ApplyBlast

Radiopharmaceutical Production Operator II

Telix Pharmaceuticals

2 days ago

3.6 on Glassdoor

Wilkes-Barre, Pennsylvania, United States

Onsite

Full Time

Medior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

The Radiopharmaceutical Production Operator II role supports the international rollout of an approved prostate cancer imaging agent and advances late clinical-stage products for oncology and rare diseases. This on-site position involves routine radiochemical synthesis, purification, compounding, and quality control functions at a cyclotron facility, ensuring compliance with cGMP, radiation safety, and regulatory requirements. The role requires operating and maintaining manufacturing equipment, performing quality control testing, and mentoring junior operators.

Responsibilities

Execute routine radiochemical synthesis and quality control testing
Operate and maintain cyclotrons and automated chemistry modules
Train and mentor junior production operators

Skills

Qualifications

Associates degree in ChemistryAssociates degree in RadiochemistryAssociates degree in Biochemistry

About Telix Pharmaceuticals

telixpharma.com

Headquarters

North Melbourne, Victoria, Australia

Company Size

201-500 employees

Founded

2015

View Profile

Telix Pharmaceuticals is a global, commercial‑stage biopharmaceutical company developing diagnostic and therapeutic “theranostic” products that use targeted radiation to detect and treat cancer. It advances radiopharmaceuticals through clinical development, regulatory approval, manufacturing and commercialisation to bring imaging agents and targeted therapies to patients. Telix works with the nuclear medicine community and international partners to scale access and improve outcomes. Its stated mission is to help patients with cancer live longer with better quality lives.